Kiniksa Pharmaceuticals International, plc APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Kiniksa Pharmaceuticals International, plc (KNSA) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $10.06 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Shareholders' Equity › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-04-28
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $10.06M, a 29.79% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $10.23M.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $10.14M, a 29.62% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $8.88M, a 20.55% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $37.00M, a 20.56% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $30.69M, a 13.05% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $27.15M, a 8.08% increase from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $25.12M, a 0.21% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-03-31 | $10.06M 10-Q · filed 2026-04-28 | $20.29M derived: sum of 2 quarters · filed 2026-04-28 | $30.43M derived: sum of 3 quarters · filed 2026-04-28 | $39.31M derived: sum of 4 quarters · filed 2026-04-28 |
| 2025-12-31 | $10.23M derived: 10-K 12 month − 3 quarters · filed 2026-02-24 | $20.38M derived: sum of 2 quarters · filed 2026-02-24 | $29.25M derived: sum of 3 quarters · filed 2026-02-24 | $37.00M 10-K · filed 2026-02-24 |
| 2025-09-30 | $10.14M 10-Q · filed 2025-10-28 | $19.02M derived: sum of 2 quarters · filed 2025-10-28 | $26.77M derived: sum of 3 quarters · filed 2026-04-28 | |
| 2025-06-30 | $8.88M 10-Q · filed 2025-10-28 | $16.62M derived: sum of 2 quarters · filed 2026-04-28 | ||
| 2025-03-31 | $7.75M 10-Q · filed 2026-04-28 | |||
| 2024-12-31 | $30.69M 10-K · filed 2026-02-24 | |||
| 2024-09-30 | $7.83M 10-Q · filed 2025-10-28 | $15.19M derived: sum of 2 quarters · filed 2025-10-28 | $22.39M derived: sum of 3 quarters · filed 2025-10-28 | |
| 2024-06-30 | $7.36M 10-Q · filed 2025-10-28 | $14.57M derived: sum of 2 quarters · filed 2025-10-28 | ||
| 2024-03-31 | $7.21M 10-Q · filed 2025-10-28 | |||
| 2023-12-31 | $27.15M 10-K · filed 2026-02-24 | |||
| 2023-09-30 | $6.79M 10-Q · filed 2024-10-29 | $13.26M derived: sum of 2 quarters · filed 2024-10-29 | $19.38M derived: sum of 3 quarters · filed 2024-10-29 | |
| 2023-06-30 | $6.47M 10-Q · filed 2024-10-29 | $12.59M derived: sum of 2 quarters · filed 2024-10-29 | ||
| 2023-03-31 | $6.12M 10-Q · filed 2024-10-29 | |||
| 2022-12-31 | $25.12M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $6.04M 10-Q · filed 2023-11-02 | $12.72M derived: sum of 2 quarters · filed 2023-11-02 | $18.75M derived: sum of 3 quarters · filed 2023-11-02 | |
| 2022-06-30 | $6.68M 10-Q · filed 2023-11-02 | $12.71M derived: sum of 2 quarters · filed 2023-11-02 | ||
| 2022-03-31 | $6.03M 10-Q · filed 2023-11-02 | |||
| 2021-12-31 | $25.17M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $6.20M 10-Q · filed 2022-11-03 | $11.92M derived: sum of 2 quarters · filed 2022-11-03 | $19.04M derived: sum of 3 quarters · filed 2022-11-03 | |
| 2021-06-30 | $5.72M 10-Q · filed 2022-11-03 | $12.84M derived: sum of 2 quarters · filed 2022-11-03 | ||
| 2021-03-31 | $7.13M 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $20.88M 10-K · filed 2023-03-02 | |||
| 2020-09-30 | $5.56M 10-Q · filed 2021-11-04 | $10.41M derived: sum of 2 quarters · filed 2021-11-04 | $14.62M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $4.85M 10-Q · filed 2021-11-04 | $9.06M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $4.21M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $15.08M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | $3.76M 10-Q · filed 2020-11-05 | $7.22M derived: sum of 2 quarters · filed 2020-11-05 | $10.12M derived: sum of 3 quarters · filed 2020-11-05 | $12.70M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $3.46M 10-Q · filed 2020-11-05 | $6.36M derived: sum of 2 quarters · filed 2020-11-05 | $8.94M derived: sum of 3 quarters · filed 2021-02-25 | $10.44M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.89M 10-Q · filed 2020-11-05 | $5.47M derived: sum of 2 quarters · filed 2021-02-25 | $6.98M derived: sum of 3 quarters · filed 2021-02-25 | $8.04M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.08M derived: sum of 2 quarters · filed 2021-02-25 | $5.14M derived: sum of 3 quarters · filed 2021-02-25 | $5.70M 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.50M 10-Q · filed 2019-11-05 | $2.56M derived: sum of 2 quarters · filed 2019-11-05 | $3.12M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.06M 10-Q · filed 2019-11-05 | $1.62M 10-Q · filed 2018-08-06 | ||
| 2018-03-31 | $558.00K 10-Q · filed 2019-11-05 | |||
| 2017-12-31 | $897.00K 10-K · filed 2019-03-12 |